The autosomal recessive AP1G1-related neurodevelopmental disorder (USRISR, OMIM 619548), caused by biallelic missense variants in AP1G1, which encodes the gamma-1 adaptin subunit of the heterotetrameric clathrin adaptor protein complex 1 (AP-1). It was delineated in the same 2021 series that defined the dominant form, in two families carrying p.Pro246His and p.Met369Val, with mild to severe intellectual disability, developmental delay and epilepsy. **The recessive missense proteins still build the complex.** This is the finding that separates this entry from its dominant sibling rather than merely restating the inheritance pattern. Functional study of the recessively inherited missense variants found no apparent impact on the interaction of AP1-gamma-1 with the other AP-1 subunits, and instead showed an effect on the endosome recycling pathway. So the lesion is not failure to assemble AP-1; it is an assembled complex that mis-handles cargo on the recycling arm. Contrast the dominant form, whose reported allele classes include frameshift, splice-site and whole-gene deletion alongside missense, and where the disease can therefore be reached by simply having less gamma-1 adaptin. A pure haploinsufficiency route is not available to a recessive missense genotype: both copies encode a protein that is made and incorporated. **The zebrafish rescue is the functional argument that these alleles are pathogenic.** Knocking out ap1g1 in zebrafish is severely deleterious and lethal, and the phenotype is significantly rescued by wild-type AP1G1 mRNA but not by transcripts encoding the missense variants. That is a loss-of-function readout for alleles whose defect is not loss of complex assembly. **Whether this should be one disease with the dominant form is genuinely open**, and is recorded in `discussions` rather than settled here. The founding cohort delineated both forms in one series, and the follow-up literature describes the dominant and recessive forms as having overlapping clinical features. What keeps them apart in this knowledge base is that MONDO carries them as siblings with distinct OMIM numbers, and that the molecular lesions reported for each are different in kind.
Ask a research question about Usmani-Riazuddin Syndrome, Autosomal Recessive. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Usmani-Riazuddin Syndrome, Autosomal Recessive
category: Mendelian
creation_date: "2026-09-22T13:30:00Z"
synonyms:
- USRISR
- AP1G1-related autosomal recessive neurodevelopmental disorder
description: >-
The autosomal recessive AP1G1-related neurodevelopmental disorder (USRISR, OMIM
619548), caused by biallelic missense variants in AP1G1, which encodes the gamma-1
adaptin subunit of the heterotetrameric clathrin adaptor protein complex 1 (AP-1).
It was delineated in the same 2021 series that defined the dominant form, in two
families carrying p.Pro246His and p.Met369Val, with mild to severe intellectual
disability, developmental delay and epilepsy.
**The recessive missense proteins still build the complex.** This is the finding
that separates this entry from its dominant sibling rather than merely restating
the inheritance pattern. Functional study of the recessively inherited missense
variants found no apparent impact on the interaction of AP1-gamma-1 with the other
AP-1 subunits, and instead showed an effect on the endosome recycling pathway. So
the lesion is not failure to assemble AP-1; it is an assembled complex that
mis-handles cargo on the recycling arm.
Contrast the dominant form, whose reported allele classes include frameshift,
splice-site and whole-gene deletion alongside missense, and where the disease can
therefore be reached by simply having less gamma-1 adaptin. A pure
haploinsufficiency route is not available to a recessive missense genotype: both
copies encode a protein that is made and incorporated.
**The zebrafish rescue is the functional argument that these alleles are
pathogenic.** Knocking out ap1g1 in zebrafish is severely deleterious and lethal,
and the phenotype is significantly rescued by wild-type AP1G1 mRNA but not by
transcripts encoding the missense variants. That is a loss-of-function readout for
alleles whose defect is not loss of complex assembly.
**Whether this should be one disease with the dominant form is genuinely open**,
and is recorded in `discussions` rather than settled here. The founding cohort
delineated both forms in one series, and the follow-up literature describes the
dominant and recessive forms as having overlapping clinical features. What keeps
them apart in this knowledge base is that MONDO carries them as siblings with
distinct OMIM numbers, and that the molecular lesions reported for each are
different in kind.
disease_term:
preferred_term: Usmani-Riazuddin syndrome, autosomal recessive
term:
id: MONDO:0859196
label: Usmani-Riazuddin syndrome, autosomal recessive
parents:
- Neurodevelopmental Disorder
references:
- reference: PMID:34102099
title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
- reference: PMID:41226632
title: "Usmani-Riazuddin Syndrome: Functional Characterization of a Novel c.196G>A Variant in the AP1G1 Gene and Phenotypic Insights Using Zebrafish as a Vertebrate Model."
inheritance:
- name: Autosomal recessive
description: >-
Biallelic AP1G1 missense variants. Two recessive families were reported in the
founding series, against nine with de novo heterozygous alleles, so the recessive
form is the rarer half of an already rare disorder.
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We conclude that de novo and bi-allelic variants in AP1G1 are associated with neurodevelopmental disorder in diverse populations."
explanation: >-
Establishes the biallelic allele class as disease-causing. The sentence naming the
two specific recessive alleles could not be used as a snippet - see the bracket
note in `notes:` - so the allele identities are carried in `variants:` and in
prose rather than in this quote.
genetic:
- name: AP1G1
notes: >-
AP1G1 encodes AP1-gamma-1, the gamma-1 subunit of the heterotetrameric adaptor
protein complex 1. AP-1 selects cargo and nucleates clathrin-coated vesicles at
the trans-Golgi network and on endosomes, and is required for polarized delivery
of somatodendritic membrane proteins in neurons.
relationship_type: CAUSATIVE
gene_term:
preferred_term: AP1G1
term:
id: hgnc:555
label: AP1G1
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We conclude that de novo and bi-allelic variants in AP1G1 are associated with neurodevelopmental disorder in diverse populations."
explanation: >-
The gene-disease assertion for both forms, stated as the study's conclusion.
variants:
- name: AP1G1 p.Pro246His
description: >-
One of the two founding recessive alleles, c.737C>A. Biallelic in one of the two
recessive families.
variant_type: single nucleotide variant
clinical_significance: PATHOGENIC
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Functional studies of the recessively inherited missense variants revealed no apparent impact on the interaction of AP1γ1 with other subunits of the AP-1 complex but rather showed to affect the endosome recycling pathway."
explanation: >-
Establishes that this allele is one of the recessively inherited missense variants
that were functionally studied, and what that study found. The sentence that names
the allele by its HGVS designation could not be quoted - see the bracket note in
`notes:`.
- name: AP1G1 p.Met369Val
description: >-
The second founding recessive allele, c.1105A>G.
variant_type: single nucleotide variant
clinical_significance: PATHOGENIC
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Functional studies of the recessively inherited missense variants revealed no apparent impact on the interaction of AP1γ1 with other subunits of the AP-1 complex but rather showed to affect the endosome recycling pathway."
explanation: >-
Establishes that this allele is one of the recessively inherited missense variants
that were functionally studied, and what that study found. The sentence that names
the allele by its HGVS designation could not be quoted - see the bracket note in
`notes:`.
pathophysiology:
- name: Biallelic AP1G1 Missense Substitution
description: >-
Both AP1G1 alleles carry a missense substitution. In silico analysis and 3D
protein modelling predicted altered AP1-gamma-1 folding for the missense variants,
and altered AP1-gamma-1 levels were observed in heterologous cells, so the protein
is made but is not normal.
biological_scale: MOLECULAR
mechanism_confidence: ESTABLISHED
genes:
- preferred_term: AP1G1
term:
id: hgnc:555
label: AP1G1
genetic_context:
variant_origin: GERMLINE
zygosity: HOMOZYGOUS
functional_impact_category: PARTIAL_LOSS_OF_FUNCTION
description: >-
Recorded as PARTIAL_LOSS_OF_FUNCTION rather than LOSS_OF_FUNCTION. The zebrafish
rescue failure is a loss-of-function readout, but the same alleles retain normal
interaction with the other AP-1 subunits, so the protein is not simply absent or
non-functional - it assembles and then misroutes. A full LOSS_OF_FUNCTION
grading would assert more than the functional data show.
biological_processes:
- preferred_term: protein folding
modifier: ABNORMAL
term:
id: GO:0006457
label: protein folding
downstream:
- target: Assembled AP-1 Complex With Perturbed Endosome Recycling
causal_link_type: DIRECT
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: COMPUTATIONAL
snippet: "In silico analysis and 3D protein modeling simulation predicted alteration of AP1γ1 protein folding for missense variants, which was consistent with the observed altered AP1γ1 levels in heterologous cells."
explanation: >-
The folding prediction, graded COMPUTATIONAL because the quoted claim is a
modelling result. Note the sentence also reports a heterologous-cell measurement
described as consistent with it; that measurement is in vitro and the sentence
mixes the two, which is why the grading follows the leading claim and the
explanation says so.
- name: Assembled AP-1 Complex With Perturbed Endosome Recycling
description: >-
The defining node of this entry. The recessively inherited missense variants show
no apparent impact on the interaction of AP1-gamma-1 with the other subunits of
the AP-1 complex, and instead affect the endosome recycling pathway. The complex
forms; what fails is what it does on the recycling arm.
biological_scale: MOLECULAR
mechanism_confidence: ESTABLISHED
protein_complexes:
- preferred_term: AP-1 adaptor complex
term:
id: GO:0030121
label: AP-1 adaptor complex
cellular_components:
- preferred_term: recycling endosome
term:
id: GO:0055037
label: recycling endosome
biological_processes:
- preferred_term: endocytic recycling
modifier: DECREASED
term:
id: GO:0032456
label: endocytic recycling
downstream:
- target: Impaired Polarized Delivery of Somatodendritic Membrane Proteins
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Functional studies of the recessively inherited missense variants revealed no apparent impact on the interaction of AP1γ1 with other subunits of the AP-1 complex but rather showed to affect the endosome recycling pathway."
explanation: >-
The single most important sentence for this entry. It is specifically about the
recessively inherited variants, it rules out a complex-assembly defect, and it
names the pathway that is affected instead.
- name: Impaired Polarized Delivery of Somatodendritic Membrane Proteins
description: >-
AP-1 mediates selective intracellular vesicular trafficking and the polarized
localization of somatodendritic proteins in neurons. A recycling defect in that
machinery is expected to mis-place membrane proteins in the neuronal
somatodendritic compartment.
This node is an inference, and is marked PROVISIONAL for that reason. What is
established is that AP-1 does this job and that these alleles disturb endosome
recycling; what has not been measured in a neuron carrying a recessive AP1G1
genotype is the mis-delivery itself.
biological_scale: CELLULAR
mechanism_confidence: PROVISIONAL
cell_types:
- preferred_term: neuron
term:
id: CL:0000540
label: neuron
biological_processes:
- preferred_term: intracellular protein transport
modifier: DECREASED
term:
id: GO:0006886
label: intracellular protein transport
downstream:
- target: Disrupted Neurodevelopment
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: OTHER
quote_role: BACKGROUND
directness: INDIRECT
snippet: "Adaptor protein (AP) complexes mediate selective intracellular vesicular trafficking and polarized localization of somatodendritic proteins in neurons."
explanation: >-
The statement of what AP complexes do in neurons. It is the opening sentence of
the paper's background and is not a finding of this study, so it is graded
BACKGROUND; it is graded OTHER because it describes established cell biology
rather than a study of any particular design, and INDIRECT because the claim it
is cited for - that these alleles impair that delivery - follows from it only by
an inference step.
- name: Disrupted Neurodevelopment
description: >-
The convergence node onto the clinical phenotype. Loss of ap1g1 in zebrafish
produces severe morphological defects and lethality, rescued by wild-type but not
mutant human AP1G1 mRNA, which is the organism-level evidence that this gene's
function is required for normal development.
biological_scale: ORGANISM
mechanism_confidence: ESTABLISHED
downstream:
- target: Intellectual disability
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- target: Global developmental delay
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- target: Seizure
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Knocking out ap1g1 in zebrafish leads to severe morphological defect and lethality, which was significantly rescued by injection of wild-type AP1G1 mRNA and not by transcripts encoding the missense variants."
explanation: >-
The rescue experiment. Note carefully what it does and does not show: the
missense transcripts fail to rescue a null, which establishes that they are
hypofunctional, but the assay is a null background, not a biallelic missense
background, so it does not reproduce the human recessive genotype.
phenotypes:
- category: Neurologic
name: Intellectual disability
description: >-
Mild to severe intellectual disability, reported across the AP1G1 cohort including
the recessive families.
phenotype_term:
preferred_term: Intellectual disability
term:
id: HP:0001249
label: Intellectual disability
severity: variable, mild to severe
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "associated with a neurodevelopmental disorder (NDD) characterized by mild to severe ID, epilepsy, and developmental delay in eleven families from different ethnicities"
explanation: >-
The core phenotype triad. Note this describes all eleven families, dominant and
recessive together; the paper does not separate the phenotype by inheritance
mode, which is itself part of why the lump/split question is open.
- category: Neurologic
name: Global developmental delay
description: >-
Developmental delay, reported with intellectual disability and epilepsy as the
defining triad of the AP1G1 disorder.
phenotype_term:
preferred_term: Global developmental delay
term:
id: HP:0001263
label: Global developmental delay
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "mild to severe ID, epilepsy, and developmental delay in eleven families from different ethnicities"
explanation: >-
As above, the cohort-level phenotype, not separated by inheritance mode.
- category: Neurologic
name: Seizure
description: >-
Epilepsy, the third element of the reported triad.
phenotype_term:
preferred_term: Seizure
term:
id: HP:0001250
label: Seizure
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "mild to severe ID, epilepsy, and developmental delay in eleven families from different ethnicities"
explanation: >-
As above, the cohort-level phenotype, not separated by inheritance mode.
- category: Neurologic
name: Delayed speech and language development
description: >-
Speech delay is among the common signs of the AP1G1 disorder. The source sentence
describes the clinical phenotype of Usmani-Riazuddin syndrome as a whole, in a
paper that frames the dominant and recessive forms as showing overlapping clinical
features, so it is not specific to the recessive form.
phenotype_term:
preferred_term: Delayed speech and language development
term:
id: HP:0000750
label: Delayed speech and language development
evidence:
- reference: PMID:41226632
reference_title: "Usmani-Riazuddin Syndrome: Functional Characterization of a Novel c.196G>A Variant in the AP1G1 Gene and Phenotypic Insights Using Zebrafish as a Vertebrate Model."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
snippet: "The clinical phenotype is characterized by common signs such as intellectual disability, speech delay, developmental delay, hypotonia, and behavioral problems (mainly aggressive behavior), variably associated with congenital anomalies, epilepsy, spasticity, autism, bone abnormalities, vertebral and limb defects, and variable facial features (eyes and ear shape anomalies)."
explanation: >-
The syndrome's clinical description, quoted from the paper's introduction where it
summarizes the established phenotype rather than reporting its own case, hence
BACKGROUND. It separates common signs from variably associated ones; speech delay
is in the common group.
- category: Neurologic
name: Hypotonia
description: >-
Muscular tone disorder, among the common signs of the syndrome.
phenotype_term:
preferred_term: Hypotonia
term:
id: HP:0001252
label: Hypotonia
evidence:
- reference: PMID:41226632
reference_title: "Usmani-Riazuddin Syndrome: Functional Characterization of a Novel c.196G>A Variant in the AP1G1 Gene and Phenotypic Insights Using Zebrafish as a Vertebrate Model."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
snippet: "The clinical phenotype is characterized by common signs such as intellectual disability, speech delay, developmental delay, hypotonia, and behavioral problems (mainly aggressive behavior), variably associated with congenital anomalies, epilepsy, spasticity, autism, bone abnormalities, vertebral and limb defects, and variable facial features (eyes and ear shape anomalies)."
explanation: >-
Hypotonia is listed among the common signs rather than the variably associated
ones, which is the distinction this sentence draws and the reason it is curated
here without a frequency.
- category: Neurologic
name: Spasticity
description: >-
Spasticity is listed among the features VARIABLY associated with the syndrome
rather than among its common signs, and the entry keeps that distinction rather
than flattening it.
phenotype_term:
preferred_term: Spasticity
term:
id: HP:0001257
label: Spasticity
evidence:
- reference: PMID:41226632
reference_title: "Usmani-Riazuddin Syndrome: Functional Characterization of a Novel c.196G>A Variant in the AP1G1 Gene and Phenotypic Insights Using Zebrafish as a Vertebrate Model."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
snippet: "variably associated with congenital anomalies, epilepsy, spasticity, autism, bone abnormalities, vertebral and limb defects"
explanation: >-
Deliberately quoting the "variably associated" clause rather than the common-signs
clause, because that is the group the source puts spasticity in.
- category: Behavioral
name: Aggressive behavior
description: >-
Behavioural problems, mainly aggressive behaviour, are among the common signs.
phenotype_term:
preferred_term: Aggressive behavior
term:
id: HP:0000718
label: Aggressive behavior
evidence:
- reference: PMID:41226632
reference_title: "Usmani-Riazuddin Syndrome: Functional Characterization of a Novel c.196G>A Variant in the AP1G1 Gene and Phenotypic Insights Using Zebrafish as a Vertebrate Model."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
snippet: "behavioral problems (mainly aggressive behavior)"
explanation: >-
The behavioural phenotype, with the source's own qualifier that aggression is the
predominant form rather than the only one.
diagnosis:
- name: Exome or genome sequencing
description: >-
There is no biochemical or imaging marker for this disorder. Every published
proband was ascertained by exome sequencing with ACMG variant interpretation, and
the recessive form additionally requires confirming that the two variants are in
trans.
diagnosis_term:
preferred_term: whole exome sequencing
term:
id: NCIT:C101295
label: Whole Exome Sequencing
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We conclude that de novo and bi-allelic variants in AP1G1 are associated with neurodevelopmental disorder in diverse populations."
explanation: >-
The disorder is defined by its genotype, so sequencing is the diagnostic test
rather than a confirmatory one.
- name: Copy-number analysis where sequencing is uninformative
diagnosis_term:
preferred_term: whole genome sequencing for copy-number detection
term:
id: NCIT:C101294
label: Whole Genome Sequencing
description: >-
Genome sequencing has produced an AP1G1 Usmani-Riazuddin diagnosis in a patient
whose aetiology was still uncertain after gene panel testing and array CGH, by
detecting and characterising a copy-number variant those methods missed. This
matters more for a recessive disorder than a dominant one: a deletion in trans
with a sequence variant can make a heterozygote look homozygous or look negative,
depending on the assay.
evidence:
- reference: PMID:38840441
reference_title: "Whole genome sequencing for copy number variant detection to improve diagnosis and management of rare diseases."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "resulting in genetic diagnoses of PRKN-related Parkinson disease, TAOK1-related neurodevelopmental disorder, and AP1G1-related Usmani-Riazuddin syndrome."
explanation: >-
Records that a Usmani-Riazuddin diagnosis was reached by genome sequencing for
copy-number detection after panel testing and array CGH were uninformative. Note
the paper does not state which AP1G1 form that patient had.
treatments:
- name: Antiseizure medication
description: >-
Seizure management is symptom-directed. The literature establishes that epilepsy
occurs in this disorder and reports no AP1G1-specific agent choice or response
pattern, so selection follows general epilepsy practice. The same is true of the
dominant form, and the sibling entry carries this treatment on the same footing.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Anticonvulsant Therapy
term:
id: NCIT:C64172
label: Anticonvulsant Therapy
target_phenotypes:
- preferred_term: Seizure
term:
id: HP:0001250
label: Seizure
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "associated with a neurodevelopmental disorder (NDD) characterized by mild to severe ID, epilepsy, and developmental delay in eleven families from different ethnicities"
explanation: >-
Establishes epilepsy as a treatment target in this disorder. The source names no
antiseizure agent and reports no response data, so this record fixes the target
and not the choice.
- name: Developmental and rehabilitative therapy
description: >-
Physical, occupational and speech-language therapy directed at developmental delay,
speech delay and tone abnormalities. Supportive and individualized; no
disorder-specific rehabilitation protocol has been published.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: developmental and rehabilitative therapy
term:
id: NCIT:C15315
label: Rehabilitation
target_phenotypes:
- preferred_term: Global developmental delay
term:
id: HP:0001263
label: Global developmental delay
- preferred_term: Delayed speech and language development
term:
id: HP:0000750
label: Delayed speech and language development
- preferred_term: Hypotonia
term:
id: HP:0001252
label: Hypotonia
evidence:
- reference: PMID:41226632
reference_title: "Usmani-Riazuddin Syndrome: Functional Characterization of a Novel c.196G>A Variant in the AP1G1 Gene and Phenotypic Insights Using Zebrafish as a Vertebrate Model."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
snippet: "The clinical phenotype is characterized by common signs such as intellectual disability, speech delay, developmental delay, hypotonia, and behavioral problems (mainly aggressive behavior), variably associated with congenital anomalies, epilepsy, spasticity, autism, bone abnormalities, vertebral and limb defects, and variable facial features (eyes and ear shape anomalies)."
explanation: >-
Establishes the developmental, speech and tone targets this therapy addresses.
Quoted from the paper's introduction restating the established clinical picture,
hence BACKGROUND.
- name: Behavioural management
description: >-
Behavioural and psychiatric support directed at the aggressive behaviour that is
among the disorder's common signs. No AP1G1-specific behavioural intervention or
outcome has been reported.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: behavioural management
term:
id: NCIT:C15747
label: Supportive Care
target_phenotypes:
- preferred_term: Aggressive behavior
term:
id: HP:0000718
label: Aggressive behavior
evidence:
- reference: PMID:41226632
reference_title: "Usmani-Riazuddin Syndrome: Functional Characterization of a Novel c.196G>A Variant in the AP1G1 Gene and Phenotypic Insights Using Zebrafish as a Vertebrate Model."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
snippet: "behavioral problems (mainly aggressive behavior)"
explanation: >-
Establishes the behavioural target, with the source's own qualifier that
aggression is the predominant form rather than the only one.
animal_models:
- name: ap1g1 knockout zebrafish
species: Zebrafish
genotype: ap1g1 knockout
publication: PMID:34102099
description: >-
Loss of ap1g1 in zebrafish is severely deleterious and lethal. The model is used
here as a rescue assay rather than as a phenocopy: wild-type human AP1G1 mRNA
rescues, and transcripts carrying the disease missense variants do not.
modeled_mechanisms:
- target: Disrupted Neurodevelopment
relationship: PARTIALLY_RECAPITULATES
fidelity: MODERATE
model_scale: ORGANISM
description: >-
Establishes that ap1g1 function is required for normal development and that the
human missense alleles cannot supply it.
limitations: >-
The assay is rescue of a null, not a model of the human recessive state. A human
USRISR patient has two missense alleles making assembled, partly functional
complex; the fish has none, and then receives mutant mRNA. So it shows the
alleles are hypofunctional relative to wild type, and says nothing about the
residual function that biallelic missense leaves. It also cannot report the
human phenotype: lethality at an early developmental stage is not intellectual
disability or epilepsy.
divergences:
- divergence_type: PROXY_QUANTITY
materiality: QUALIFYING
description: >-
The measured quantity is rescue of morphological defect and lethality in a
null background. The quantity the node needs is impairment of neurodevelopment
in the presence of two hypomorphic alleles. Rescue failure stands in for that.
- divergence_type: SPECIES_MISMATCH
materiality: QUALIFYING
description: >-
The readout phenotype is early embryonic morphology and lethality in a fish.
The human phenotype is intellectual disability, developmental delay and
epilepsy, none of which this assay can observe.
readouts:
- name: Rescue of ap1g1-null morphology and lethality by human AP1G1 mRNA
target: Disrupted Neurodevelopment
direction: RESTORED
interpretation: >-
Wild-type transcript restores the phenotype; disease missense transcripts do
not, which grades those alleles as hypofunctional.
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "significantly rescued by injection of wild-type AP1G1 mRNA and not by transcripts encoding the missense variants"
explanation: >-
The rescue result itself.
evidence:
- reference: PMID:34102099
reference_title: "De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Knocking out ap1g1 in zebrafish leads to severe morphological defect and lethality"
explanation: >-
Establishes that the gene is required in the model organism, which is the
precondition for using it as a rescue assay.
discussions:
- discussion_id: usrisr_usrisd_one_entity
kind: KNOWLEDGE_GAP
prompt: >-
Are the autosomal dominant and autosomal recessive AP1G1 disorders one disease
with two inheritance routes, or two diseases?
attaches_to:
- pathophysiology#Assembled AP-1 Complex With Perturbed Endosome Recycling
- disease#Usmani-Riazuddin Syndrome, Autosomal Recessive
rationale: >-
This entry is curated as a separate Disease, and the reasons are not
overwhelming. They should be visible to whoever revisits this.
For separation: MONDO carries MONDO:0859174 and MONDO:0859196 as siblings under
hereditary disease with no umbrella term between them; OMIM gives them distinct
numbers, 619467 and 619548; and the reported molecular lesions differ in kind. The
dominant allele classes include frameshift, splice-site and whole-gene deletion, so
that form is reachable by reduced dosage. The recessive alleles are missense that
still assemble into AP-1 and perturb endosome recycling. Those are different
statements about the protein, not different amounts of the same one.
For merging: the founding series delineated both forms together in one cohort and
did not separate the phenotype by inheritance mode - the "mild to severe ID,
epilepsy, and developmental delay" description covers all eleven families - and the
follow-up literature calls the dominant and recessive forms clinically overlapping.
A reader is entitled to ask what a clinician would do differently.
The evidence that would settle it is a direct functional comparison. If a dominant
missense allele and a recessive missense allele are put through the same
complex-assembly and endosome-recycling assays and behave differently, the split is
mechanistic. If they behave the same and the inheritance difference is only
penetrance or dosage, the merge is right - and would then need a new umbrella
MONDO term or a mappings.mondo_mappings anchor, not reuse of one child term as the
other's parent.
proposed_experiments:
- experiment_id: ap1g1_dominant_vs_recessive_allele_comparison
name: Side-by-side assay of dominant and recessive AP1G1 missense alleles
description: >-
Run representative dominant missense alleles and the two recessive alleles
through the same two assays used in the founding study: co-immunoprecipitation
for AP-1 subunit interaction, and the endosome recycling assay. The founding
study reported the recessive alleles' behaviour in both; the comparison it does
not report is the dominant alleles run alongside them under identical conditions.
perturbations:
- name: Expression of dominant versus recessive AP1G1 missense alleles
target: pathophysiology#Assembled AP-1 Complex With Perturbed Endosome Recycling
readouts:
- name: AP-1 subunit co-immunoprecipitation and endosome recycling rate
target: pathophysiology#Assembled AP-1 Complex With Perturbed Endosome Recycling
direction: ALTERED
interpretation: >-
Dominant alleles disrupting subunit interaction while recessive alleles do not
would support two mechanisms and keep the entries separate; both classes
sparing interaction and impairing recycling equally would support one entity.
would_support:
- pathophysiology#Assembled AP-1 Complex With Perturbed Endosome Recycling
supporting_outcome:
- >-
Dominant and recessive missense alleles differ in AP-1 subunit interaction, with
only the dominant class disrupting complex assembly.
refuting_outcome:
- >-
Both allele classes spare subunit interaction and impair endosome recycling to
a comparable degree, leaving inheritance mode as the only difference.
notes: >-
Entry scope and the sibling entry. This curates the AUTOSOMAL RECESSIVE form only
(MONDO:0859196, OMIM 619548). The dominant form is curated separately as
kb/disorders/Usmani-Riazuddin_Syndrome_Autosomal_Dominant.yaml (MONDO:0859174, OMIM
619467). That entry's own `notes` records the ontology check behind treating the two
as siblings rather than parent and child, and its `discussions` carries the
ad_ar_one_entity question; this entry carries the same question from the recessive
side rather than duplicating the ontology argument.
No GeneReviews chapter exists for this disorder. Verified offline against the
committed Bookshelf index, cache/bookshelf/genereviews.csv: grep for
"Usmani", "Riazuddin", "AP1G1" and "adaptinopathy" returns no chapter.
`just check-genereviews` on this file reports NO_CHAPTER for both collections.
No mechanism module was applied, following the same search the dominant entry
records: `just list-modules` and a grep of kb/modules/ for clathrin, adaptin, AP-1,
trans-Golgi, endosome and vesicle sorting turn up nothing describing AP-1-dependent
cargo selection or endocytic recycling. `conforms_to` is left unset rather than
forced onto a module about a different trafficking step.
Snippet brackets. The founding paper writes its allele list as `c.737C>A
[p.Pro246His] and c.1105A>G [p.Met369Val]`. `linkml-reference-validator` strips
bracketed spans from the snippet but not from the cached text, so a verbatim quote
spanning that list cannot match; the two evidence items that would naturally carry
it quote neighbouring sentences instead and say so in their `explanation`. The HGVS
case is dismech#10192 and this instance is recorded there rather than worked around
by adding a `literal_bracket_patterns` entry in a curation PR.
Deep-research reconciliation, and what could not be carried across. The committed
OpenScientist report (research/Usmani-Riazuddin_Syndrome_Autosomal_Recessive-deep-research-openscientist.md)
supplies three quantitative facts that this entry does NOT record, each for the same
reason: dismech evidence needs an exact quote from a cited reference, and none of
these has a publication that states it.
- The per-phenotype FREQUENCIES for the recessive patients specifically (n = 3: speech
delay, global developmental delay, intellectual disability, hypotonia and spasticity
each 3/3; seizure and aggressive behavior each 2/3; hypertelorism, agenesis of the
corpus callosum, posteriorly rotated and low-set ears each 1/3). These are HPOA
annotations of OMIM:619548. No cached reference states a denominator for the
recessive patients - PMID:34102099's abstract describes the phenotype across all
eleven families without separating by inheritance mode - so the phenotypes below
carry no frequency.
An earlier draft of this note went further and said the phenotypes themselves could
not be curated because no sentence stated them. That was WRONG, and review caught
it: PMID:41226632, which this entry already cites, states hypotonia, speech delay,
aggressive behaviour and spasticity in its introduction, in a paper that explicitly
frames the dominant and recessive forms as clinically overlapping. Four phenotypes
are now curated from that sentence with quote_role BACKGROUND, and the "variably
associated" ones are quoted from the clause that says so rather than from the
common-signs clause. What is genuinely missing is only the frequency.
- gnomAD constraint: pLI 1.0, observed/expected LoF 0.065, LOEUF about 0.12, LoF Z
8.26, missense Z 3.42. Not recorded, because no cached publication quotes them.
kb/disorders/TCF20-Associated_Neurodevelopmental_Disorder.yaml hit the same wall
from the other side and records it in its own notes: it curates pLI because a paper
happened to state it, and leaves LOEUF uncurated because none did.
- The ClinVar classification distribution for AP1G1 (5 pathogenic, 3 likely
pathogenic, 28 uncertain, 3 likely benign), which is the clearest available summary
of how settled this gene's variant interpretation is.
Recorded here rather than silently dropped, and raised on dismech#10273.
A further case report, PMID:38665048, describes a novel AP1G1 variant under the
USRISR name and is deliberately NOT cited as evidence in this entry: the variant it
reports, p.Leu657Val, is de novo, so the case belongs to the dominant form despite the
title. It is noted here so a later curator does not read the title and add it.
Evidence concentration. Almost every claim in this entry traces to one publication,
PMID:34102099, because it is the only study that reports functional work on the
recessive alleles specifically. PMID:41226632 is cited for the overlapping-features
observation but its own functional work is on a dominant de novo allele and is not
used as evidence for recessive mechanism. That concentration is a real limitation of
the entry and not an artefact of curation effort.
review_notes: >-
entry_type decision: DISEASE. The stub left this open between DISEASE, GROUPING and a
merge into a new umbrella entry, and asked for it to be settled before curating.
GROUPING is ruled out on definition: a dismech Grouping is an explicit curated union
of existing diseases, subtypes or nested groupings, and USRISR is a single OMIM
entity with two reported alleles in two families. There is nothing to take a union
over.
A merge with the dominant form is the live alternative and is not ruled out - it is
recorded as an open discussion with the experiment that would settle it. It is not
taken now for three reasons: MONDO and OMIM both separate them; the reported
molecular lesions differ in kind rather than degree; and a merge would require a new
umbrella MONDO term or a mappings anchor, which is a change to make deliberately
rather than as a side effect of a curation pass.
Evidence discipline. The `Impaired Polarized Delivery of Somatodendritic Membrane
Proteins` node carries mechanism_confidence PROVISIONAL and its single evidence item
is graded BACKGROUND, OTHER and INDIRECT together. That triple is deliberate: the
quoted sentence is true, is from the paper's introduction, describes general AP
complex biology, and supports this node only through an inference. Grading it
HUMAN_CLINICAL or PRIMARY_RESULT would have made a background statement look like a
measurement in this disease.
The zebrafish model is recorded as PARTIALLY_RECAPITULATES with two typed
divergences rather than as a clean model. The assay is rescue of a null by mutant
mRNA, which is not the human biallelic-missense state, and its readout is embryonic
lethality, which is not the human phenotype. Both are stated in `limitations` and
typed in `divergences` rather than compressed into the fidelity tier.
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Record notes
Entry scope and the sibling entry. This curates the AUTOSOMAL RECESSIVE form only (MONDO:0859196, OMIM 619548). The dominant form is curated separately as kb/disorders/Usmani-Riazuddin_Syndrome_Autosomal_Dominant.yaml (MONDO:0859174, OMIM 619467). That entry's own `notes` records the ontology check behind treating the two as siblings rather than parent and child, and its `discussions` carries the ad_ar_one_entity question; this entry carries the same question from the recessive side rather than duplicating the ontology argument. No GeneReviews chapter exists for this disorder. Verified offline against the committed Bookshelf index, cache/bookshelf/genereviews.csv: grep for "Usmani", "Riazuddin", "AP1G1" and "adaptinopathy" returns no chapter. `just check-genereviews` on this file reports NO_CHAPTER for both collections. No mechanism module was applied, following the same search the dominant entry records: `just list-modules` and a grep of kb/modules/ for clathrin, adaptin, AP-1, trans-Golgi, endosome and vesicle sorting turn up nothing describing AP-1-dependent cargo selection or endocytic recycling. `conforms_to` is left unset rather than forced onto a module about a different trafficking step. Snippet brackets. The founding paper writes its allele list as `c.737C>A [p.Pro246His] and c.1105A>G [p.Met369Val]`. `linkml-reference-validator` strips bracketed spans from the snippet but not from the cached text, so a verbatim quote spanning that list cannot match; the two evidence items that would naturally carry it quote neighbouring sentences instead and say so in their `explanation`. The HGVS case is dismech#10192 and this instance is recorded there rather than worked around by adding a `literal_bracket_patterns` entry in a curation PR. Deep-research reconciliation, and what could not be carried across. The committed OpenScientist report (research/Usmani-Riazuddin_Syndrome_Autosomal_Recessive-deep-research-openscientist.md) supplies three quantitative facts that this entry does NOT record, each for the same reason: dismech evidence needs an exact quote from a cited reference, and none of these has a publication that states it. - The per-phenotype FREQUENCIES for the recessive patients specifically (n = 3: speech delay, global developmental delay, intellectual disability, hypotonia and spasticity each 3/3; seizure and aggressive behavior each 2/3; hypertelorism, agenesis of the corpus callosum, posteriorly rotated and low-set ears each 1/3). These are HPOA annotations of OMIM:619548. No cached reference states a denominator for the recessive patients - PMID:34102099's abstract describes the phenotype across all eleven families without separating by inheritance mode - so the phenotypes below carry no frequency. An earlier draft of this note went further and said the phenotypes themselves could not be curated because no sentence stated them. That was WRONG, and review caught it: PMID:41226632, which this entry already cites, states hypotonia, speech delay, aggressive behaviour and spasticity in its introduction, in a paper that explicitly frames the dominant and recessive forms as clinically overlapping. Four phenotypes are now curated from that sentence with quote_role BACKGROUND, and the "variably associated" ones are quoted from the clause that says so rather than from the common-signs clause. What is genuinely missing is only the frequency. - gnomAD constraint: pLI 1.0, observed/expected LoF 0.065, LOEUF about 0.12, LoF Z 8.26, missense Z 3.42. Not recorded, because no cached publication quotes them. kb/disorders/TCF20-Associated_Neurodevelopmental_Disorder.yaml hit the same wall from the other side and records it in its own notes: it curates pLI because a paper happened to state it, and leaves LOEUF uncurated because none did. - The ClinVar classification distribution for AP1G1 (5 pathogenic, 3 likely pathogenic, 28 uncertain, 3 likely benign), which is the clearest available summary of how settled this gene's variant interpretation is. Recorded here rather than silently dropped, and raised on dismech#10273. A further case report, PMID:38665048, describes a novel AP1G1 variant under the USRISR name and is deliberately NOT cited as evidence in this entry: the variant it reports, p.Leu657Val, is de novo, so the case belongs to the dominant form despite the title. It is noted here so a later curator does not read the title and add it. Evidence concentration. Almost every claim in this entry traces to one publication, PMID:34102099, because it is the only study that reports functional work on the recessive alleles specifically. PMID:41226632 is cited for the overlapping-features observation but its own functional work is on a dominant de novo allele and is not used as evidence for recessive mechanism. That concentration is a real limitation of the entry and not an artefact of curation effort.
USRISR is a Mendelian disorder caused by bi-allelic (recessive) variants in AP1G1. In the disease-defining study, Usmani et al. (2021) reported two bi-allelic missense variants — c.737C>A [p.Pro246His] and c.1105A>G [p.Met369Val] — alongside eight de novo heterozygous variants that cause the allelic dominant disorder (USRISD, OMIM #619467). OMIM designates the recessive form USRISR #619548 and the dominant form USRISD #619467; the causal gene AP1G1 is catalogued as MIM *603533.
"Here, we report two bi-allelic (c.737C>A [p.Pro246His] and c.1105A>G [p.Met369Val]) and eight de novo heterozygous variants" — PMID: 34102099
The molecular basis lies in the normal role of adaptor protein complexes: "Adaptor protein (AP) complexes mediate selective intracellular vesicular trafficking and polarized localization of somatodendritic proteins in neurons" (PMID: 34102099). AP1G1 encodes the γ1 subunit of AP-1, so bi-allelic hypomorphic alleles compromise this trafficking machinery.
USRISR is characterized by multisystemic involvement. Gnazzo et al. (2024) summarize the syndrome as being "characterized by multisystemic involvement including intellectual disability, speech and developmental delay, behavioral anomalies, muscular tone disorders, seizures, limb defects, and unspecified facial gestalt" (PMID: 38665048). The original cohort (PMID: 34102099) established the three core neurodevelopmental features: developmental delay, intellectual disability, and epilepsy.
AP1G1 encodes the γ1 subunit of the heterotetrameric AP-1 adaptor complex, which acts with clathrin in vesicular transport between the trans-Golgi network (TGN) and early/recycling endosomes. AP-1 is described as "a subunit of the adaptor protein complex 1 (AP-1), a key component of the intracellular protein trafficking machinery" (PMID: 39269494).
Loss of the γ1 subunit disrupts polarized cargo sorting: in MDCK cells, "silencing of clathrin or the γ1 subunit of clathrin adaptor AP-1 by RNA interference … disrupted apical localization of megalin, causing its redistribution to the basolateral membrane" (PMID: 31091172). In neurons, this same machinery governs polarized somatodendritic protein localization; the bi-allelic missense variants (p.Pro246His, p.Met369Val) are predicted hypomorphic, impairing AP-1 cargo handling.
Critically, functional studies of the two recessive missense variants revealed a mechanism distinct from the dominant alleles: they had no apparent impact on AP1γ1's interaction with other AP-1 subunits, but instead affected the endosome-recycling pathway. In silico/3D modeling predicted altered protein folding, consistent with observed alterations in AP1γ1 protein levels in heterologous cells (PMID: 34102099).
The gene is essential in vivo: knocking out ap1g1 in zebrafish caused severe morphological defects and lethality, significantly rescued by wild-type but not variant AP1G1 mRNA. A 2025 study confirmed that ap1g1 knockout is lethal at the gastrula stage and rescued by human wild-type mRNA, describing AP-1 as "a heterotetrameric essential for intracellular vesicular trafficking and polarized localization of somato-dendritic proteins in neurons" (PMID: 41226632).
The defining cohort (PMID: 34102099) comprised 11 families of diverse ethnicities, including Pakistani families in which the recessive form segregated (consistent with consanguinity). The allelic architecture is summarized below.
| Inheritance | Variant (cDNA) | Protein | Type |
|---|---|---|---|
| Recessive (bi-allelic) | c.737C>A | p.Pro246His | Missense |
| Recessive (bi-allelic) | c.1105A>G | p.Met369Val | Missense |
| Dominant (de novo) | — | p.Arg15Gln | Missense |
| Dominant (de novo) | — | p.Arg35Trp | Missense |
| Dominant (de novo) | — | p.Arg35Gln | Missense |
| Dominant (de novo) | — | p.Gln249His | Missense |
| Dominant (de novo) | — | p.Pro820Arg | Missense |
| Dominant (de novo) | — | p.Gln77Lysfs*11 | Frameshift |
| Dominant (de novo) | — | p.Glu133Aspfs*37 | Frameshift |
| Dominant (de novo) | c.928-2A>C | (splice acceptor) | Splice-site |
| Dominant (de novo, later report) | c.196G>A | p.Gly66Arg | Missense (dominant-negative) |
The phenotype spanned mild to severe intellectual disability, epilepsy, and developmental delay. A subsequently reported de novo variant, c.196G>A/p.Gly66Arg, exhibited a dominant-negative effect (PMID: 41226632).
Curated HPO annotations for OMIM:619548 / MONDO:0859196 (source PMID: 34102099; n = 3 recessive patients):
| Phenotype | HPO term | Frequency (n=3) |
|---|---|---|
| Delayed speech and language development | HP:0000750 | 3/3 (100%) |
| Global developmental delay | HP:0001263 | 3/3 (100%) |
| Intellectual disability | HP:0001249 | 3/3 (100%) |
| Hypotonia | HP:0001252 | 3/3 (100%) |
| Spasticity | HP:0001257 | 3/3 (100%) |
| Seizure | HP:0001250 | 2/3 (67%) |
| Aggressive behavior | HP:0000718 | 2/3 (67%) |
| Hypertelorism | HP:0000316 | 1/3 (33%) |
| Agenesis of corpus callosum | HP:0001274 | 1/3 (33%) |
| Posteriorly rotated ears | HP:0000358 | 1/3 (33%) |
| Low-set ears | HP:0000369 | 1/3 (33%) |
| Inheritance: Autosomal recessive | HP:0000007 | — |
Population genetic constraint data (gnomAD; ENSG00000166747, chr16q22.2) demonstrate that AP1G1 is extremely intolerant to loss-of-function: pLI = 1.0, observed/expected LoF = 0.065 (90% CI 0.037–0.121; LOEUF ≈ 0.12), LoF Z = 8.26; it is also missense-constrained (missense Z = 3.42; oe_mis = 0.75). The encoded protein (UniProt O43747, AP-1 complex subunit gamma-1, 822 aa) functions in protein sorting at the late-Golgi/TGN and endosomes, recruiting clathrin and recognizing cargo sorting signals; with AFTPH/aftiphilin it traffics transferrin from early to recycling endosomes and shuttles furin and cathepsin D. Subcellular localizations: Golgi apparatus, TGN, clathrin-coated vesicle membrane, clathrin-coated pit, and perinuclear cytoplasm. The AP1γ1-mediated adaptor complex is "essential for the formation of clathrin-coated intracellular vesicles" (PMID: 34102099).
A ClinVar query (AP1G1[gene]) returned ~50 records with a germline-classification distribution of Pathogenic 5, Likely pathogenic 3, Uncertain significance 28, Likely benign 3 — i.e., the evidence base is dominated by variants of uncertain significance, consistent with a recently delineated disease gene. No additional bi-allelic/recessive USRISR patients were identified in the literature beyond the defining cohort (PMID: 34102099) and subsequent single case reports (PMID: 38665048; PMID: 41226632).
Overview. USRISR is an ultra-rare autosomal recessive neurodevelopmental syndrome caused by bi-allelic hypomorphic missense variants in AP1G1. It belongs to the emerging group of "adaptoropathies" — Mendelian disorders of clathrin adaptor protein complexes — and produces a multisystem neurodevelopmental phenotype dominated by intellectual disability, developmental/speech delay, tone abnormalities, and epilepsy.
Key identifiers. - OMIM: #619548 (recessive form USRISR); allelic dominant form USRISD #619467; gene AP1G1 MIM *603533 - MONDO: MONDO:0859196 - Gene / HGNC: AP1G1 (HGNC:555); UniProt O43747; Ensembl ENSG00000166747; chromosome 16q22.2 - Orphanet / ICD-10 / ICD-11 / MeSH: No specific dedicated codes identified; the disorder maps to general categories of hereditary intellectual disability / neurodevelopmental disorder (e.g., ICD-11 6A00 range for disorders of intellectual development). Not available as disease-specific codes at time of writing.
Synonyms / alternative names: Usmani-Riazuddin syndrome, autosomal recessive; USRISR; AP1G1-related neurodevelopmental disorder (recessive). The allelic dominant disorder is USRISD.
Data provenance: Information is derived from aggregated disease-level resources (OMIM, HPO, gnomAD, ClinVar, UniProt) and individual-patient primary literature (small case cohorts / case reports), not from EHR-scale datasets.
Causal factors — genetic. USRISR is a purely monogenic genetic disorder. The primary cause is bi-allelic (homozygous or compound heterozygous) missense variants in AP1G1 (p.Pro246His and p.Met369Val in the defining cohort). There is no environmental, infectious, or acquired contribution to disease causation.
Genetic risk factors. The causal variants are the recessive AP1G1 missense alleles. Consanguinity is a key facilitating factor for the recessive form (the defining cohort included consanguineous/Pakistani families). No modifier loci or susceptibility variants have been established.
Environmental risk factors / protective factors / gene–environment interactions: Not applicable / not available. As a fully penetrant Mendelian recessive disorder, no environmental risk factors, protective factors, or gene–environment interactions have been described. Genetic "protection" derives simply from carrying at most one variant allele (heterozygous carriers are unaffected).
USRISR is a multisystem neurodevelopmental disorder (see Finding 6 for the full HPO-annotated frequency table). Phenotype types span: - Cognitive/developmental (symptoms/signs): intellectual disability (HP:0001249), global developmental delay (HP:0001263), delayed speech/language (HP:0000750) — each 3/3 in recessive patients. - Neuromuscular signs: hypotonia (HP:0001252) and spasticity (HP:0001257) — each 3/3; these co-occurring tone abnormalities reflect central nervous system involvement. - Neurological: seizures (HP:0001250) in ~2/3. - Behavioral: aggressive behavior (HP:0000718) in ~2/3. - Dysmorphic / structural: hypertelorism (HP:0000316), posteriorly rotated ears (HP:0000358), low-set ears (HP:0000369), and agenesis of the corpus callosum (HP:0001274) — each ~1/3.
Characteristics: age of onset is neonatal/infantile to early childhood (developmental delay evident from infancy); severity is variable (mild to severe); course is generally static/non-progressive in the developmental sense (a neurodevelopmental, not neurodegenerative, disorder), though epilepsy may be episodic. Quality-of-life impact is substantial owing to intellectual disability, communication impairment, motor dysfunction, and behavioral challenges requiring lifelong support; no disease-specific QoL instrument data (EQ-5D/SF-36) are available.
Not applicable. USRISR is a monogenic recessive disorder with no established environmental, lifestyle, or infectious contribution. AP-1 is broadly exploited by pathogens (e.g., Hepatitis E virus co-opts AP-1 for capsid trafficking, PMID: 39117755), but this reflects general cell biology and has no etiologic role in USRISR.
Ordered causal chain (recessive form):
Branch (dominant allelic disorder, for contrast): Haploinsufficient (frameshift/splice) or dominant-negative (p.Gly66Arg) alleles → disrupt AP-1 assembly/stoichiometry → overlapping neurodevelopmental phenotype (USRISD).
Molecular pathway / cellular process: clathrin-dependent vesicular trafficking (TGN ↔ early/recycling endosomes); AP-1 recruits clathrin and recognizes cargo sorting motifs; partners with AFTPH/aftiphilin to recycle transferrin and shuttle furin and cathepsin D. GO terms: intracellular protein transport (GO:0006886), clathrin-coated vesicle (GO:0030136), endosome to plasma membrane / recycling endosome (GO:0055037), establishment of protein localization / neuron projection development. Cell types (CL): neuron (CL:0000540), notably somatodendritic compartments. The mechanism is a trafficking loss-of-function ("adaptoropathy"); no immune, metabolic-deficiency, oxidative, or fibrotic mechanism is implicated. No disease-specific transcriptomic/proteomic/metabolomic profiling exists.
No disease-specific or disease-modifying therapy exists. Management is supportive and symptomatic: - Pharmacotherapy: anti-seizure medications (NCIT: Anticonvulsant Agent) for epilepsy; behavioral/psychiatric medications as indicated for aggression/behavioral anomalies. No pharmacogenomic guidance specific to USRISR. - Rehabilitative / supportive care: physical therapy, occupational therapy, speech-language therapy (NCIT: Rehabilitation Therapy / Speech Therapy), special education, and developmental support; nutritional and tone management. - Advanced / experimental therapeutics: none — no gene therapy, RNA-based, cell, or targeted therapies are in development or trials for USRISR (no NCT identifiers). Gene-restoration is conceptually plausible given the recessive loss-of-function mechanism but is entirely investigational. - Genetic counseling is a core component of care (see Prevention).
Bi-allelic AP1G1 missense variants (p.Pro246His, p.Met369Val) [GERMLINE, RECESSIVE]
|
v (predicted misfolding; reduced protein level — in vitro)
Reduced / altered AP1-gamma1 subunit
|
| NOTE: AP-1 complex ASSEMBLY preserved
| (subunit interactions intact — distinguishes
| recessive alleles from dominant ones)
v
Impaired ENDOSOME-RECYCLING arm of AP-1 trafficking (demonstrated)
|
v (inferred for neurons; shown for epithelial cargo e.g. megalin)
Mislocalization of polarized somatodendritic membrane cargo in neurons
|
v
Disturbed neuronal development / connectivity / excitability (inferred)
|
---------------------------------------------------------------
| | | | | |
v v v v v v
Global Intellectual Speech Hypotonia/ Seizures CC agenesis /
dev. delay disability delay spasticity (~2/3) dysmorphism (~1/3)
(3/3) (3/3) (3/3) (3/3)
The unifying interpretation is that USRISR is a clathrin adaptor trafficking disorder ("adaptoropathy"). The recessive missense alleles are hypomorphic and act downstream of complex assembly, selectively degrading the endosome-recycling function of AP-1. Because AP-1 governs polarized somatodendritic protein localization in neurons, this trafficking deficit converges on a neurodevelopmental phenotype. This mechanistic model places USRISR firmly alongside other AP-complex disorders such as MEDNIK/IDEDNIK syndrome (AP1S1), reinforcing the concept that defective clathrin adaptor-mediated cargo sorting is a recurrent basis for syndromic intellectual disability.
| PMID | Title (abbrev.) | Role / contribution | Evidence type |
|---|---|---|---|
| 34102099 | De novo and bi-allelic variants in AP1G1 cause NDD… | Disease-defining study: recessive & dominant variants, endosome-recycling mechanism, zebrafish rescue | Human clinical + in vitro + model organism |
| 38665048 | Usmani-Riazuddin syndrome can have a recognizable phenotype… | Delineates recognizable multisystem phenotype; novel variant | Human clinical (case report) |
| 41226632 | Functional characterization of a novel c.196G>A variant | Confirms zebrafish essentiality/rescue; dominant-negative allele | Model organism + in vitro |
| 38840441 | WGS for CNV detection in rare diseases | Demonstrates WGS diagnostic utility for AP1G1/USRISR | Human clinical (diagnostics) |
| 31091172 | Clathrin and AP-1 control apical trafficking of megalin | Mechanistic proof that γ1-subunit loss disrupts polarized sorting | In vitro (MDCK) |
| 39269494 | Revising pathogenesis of AP1S1-related MEDNIK… | AP-1 as core trafficking machinery; differential-diagnosis context | Human clinical + computational |
| 39117755 | AP-1 essential for HEV ORF2 trafficking | Supports AP-1 role in TGN↔recycling-endosome transport | In vitro (virology) |
| 42668171; 41451970 | AP-1 in B. cinerea / P. falciparum | Cross-species conservation of AP-1 γ-subunit trafficking | Model organism |
Consistency: All lines of evidence converge — human genetics (bi-allelic segregation), in vitro functional assays (reduced protein, endosome-recycling defect), structural modeling, and in-vivo zebrafish rescue — supporting a robust gene–disease relationship despite the small patient numbers.
Report compiled from an autonomous multi-iteration investigation (5 iterations; 8 confirmed findings; 13 papers reviewed). Evidence types are annotated throughout as human clinical, in vitro, model organism, or computational.
Checked with linkml-reference-validator 0.2.1.
| Outcome | Count |
|---|---|
| References checked | 10 |
| Resolved | 10 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| References weighed for topical relevance | 10 |
| On topic | 6 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 27 |
| Resolved | 24 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 3 |
| Terms whose name was checked | 15 |
| Terms named correctly | 8 |
| Terms named as a different term | 0 |
| Terms whose name is worth a second look | 7 |
The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
HP:0001252 (2 mentions) - the report calls it "Hypotonia", "Neuromuscular signs: hypotonia"; HP calls it Hypotonia**, and lists "Muscular hypotonia" among its other namesHP:0001250 (2 mentions) - the report calls it "Seizure", "Neurological: seizures"; HP calls it Seizure**, and lists "Epileptic seizure" among its other namesHP:0000718 (2 mentions) - the report calls it "Aggressive behavior", "Behavioral: aggressive behavior"; HP calls it Aggressive behavior**HP:0000316 (2 mentions) - the report calls it "Hypertelorism", "Dysmorphic / structural: hypertelorism"; HP calls it Hypertelorism**, and lists "Ocular hypertelorism" among its other namesHP:0000007 (2 mentions) - the report calls it "Inheritance: Autosomal recessive", "autosomal recessive", "Inheritance pattern: autosomal recessive"; HP calls it Autosomal recessive inheritance**UBERON:0000955 (1 mention) - the report calls it "central nervous system / brain"; UBERON calls it brain, and lists "suprasegmental levels of nervous system" among its other namesUBERON:0002336 (1 mention) - the report calls it "corpus callosum", "Secondary structures: corpus callosum"; UBERON calls it corpus callosumThe report gives these identifiers more than one name of its own:
HP:0001252 - called "Hypotonia", "Neuromuscular signs:** hypotonia"HP:0001250 - called "Seizure", "Neurological:** seizures"HP:0000718 - called "Aggressive behavior", "Behavioral:** aggressive behavior"HP:0000316 - called "Hypertelorism", "Dysmorphic / structural:** hypertelorism"HP:0000007 - called "Inheritance: Autosomal recessive", "autosomal recessive", "Inheritance pattern: **autosomal recessive"HGNC:555 - called "AP1G1", "Gene / HGNC:* AP1G1"UBERON:0002336 - called "corpus callosum", "Secondary structures: corpus callosum"Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: OMIM, Taxon.
24 of 27 terms resolved to a current term; the rest could not be looked up either way.